echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > A delegation from China pharmaceutical promotion association visited the World Trade Organization and the world intellectual property headquarters (a series of reports in Europe 3)

    A delegation from China pharmaceutical promotion association visited the World Trade Organization and the world intellectual property headquarters (a series of reports in Europe 3)

    • Last Update: 2017-07-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: on July 28, 2017, China pharmaceutical innovation promotion association led by Ding liming, President of China pharmaceutical promotion association, chairman of Beida Pharmaceutical Co., Ltd., and song Ruilin, executive chairman of China pharmaceutical promotion association, a delegation of China pharmaceutical promotion association visited the headquarters of the World Trade Organization (WTO) in Geneva, Switzerland Yi Xiaozhun, deputy director general of WTO, met with the delegation Antony Taubman, Minister of the Ministry of acquisition and competition of the intellectual property government of WTO, and Roger kampe, patent lawyer attended the meeting During the meeting, vice director general Yi Xiaozhun first introduced the general situation of WTO and the progress made by the organization in promoting stable, predictable and free trade among countries around the world At the meeting with the WTO, President Ding Liming introduced the purpose of the visit of the China Council for the promotion of drugs and the delegation Song Ruilin, executive chairman, introduced to Yi Xiaozhun, deputy director general, the current situation of China's pharmaceutical intellectual property protection, achievements in innovation and development of the pharmaceutical industry, and the recent pharmaceutical regulatory reform in China In particular, in order to encourage pharmaceutical innovation, the State Food and Drug Administration of China has proposed a proposal to establish a drug patent link system and a patent compensation system, which will have a huge impact on the development of China's pharmaceutical industry Both sides discussed the purpose and significance of the protection system of pharmaceutical intellectual property rights and the impact of patent compensation system and data protection system on innovation and imitation Vice director general Yi Xiaozhun said that he was glad to see that China has become a global patent applicant and independently developed a number of innovative drugs At present, the ongoing reform of drug patent protection system in China will have a significant impact on China and even the global drug market, so it is necessary to carefully demonstrate At the same time, he said he looked forward to carrying out research cooperation with the China Council for the promotion of drugs on the protection of pharmaceutical intellectual property rights On the same day of taking photos with WTO representatives, the delegation of China pharmaceutical promotion association also visited the headquarters of the World Intellectual Property Organization (WIPO) Minelik alemu getahun, assistant director general of the world intellectual property organization, Anatole krattiger, director of the global challenges division, and Ridha bouabid, director of the sustainable development goals of the United Nations, Marco M Aleman, Minister of patent law department and other officials attended the meeting, and held talks on topics such as drug intellectual property protection policy and global cooperation The deputy director general of getahon said that public health challenges put forward higher requirements for the integration of intellectual property system and promotion of innovation and application of medical technology As a branch of the United Nations, WIPO is committed to promoting the establishment of a unified access system for intellectual property rights Song Ruilin, executive chairman, said that China is in the process of revising the patent law and Drug Administration Law, so that innovation can have a reasonable return, people can use innovative drugs as soon as possible, and generic drugs with reasonable price and guaranteed quality; this is also the core of the drug intellectual property system The purpose of this visit to WIPO is to analyze the impact of pharmaceutical intellectual property protection on the development of the industry through face-to-face discussion Through in-depth discussion and a number of specific case studies, it is agreed that encouraging innovation is only a means, and promoting sustainable development is the core of the pharmaceutical intellectual property protection system The formulation of drug knowledge protection policy should balance the innovation and accessibility of drugs, pay attention to the connection between domestic law and international law; the length of time to grant drug patent protection is not only related to the remaining patent period of drugs, but also comprehensively consider the drug price and national financial resources and other aspects Photo with WIPO representative Ouyang Jingbo, President and vice chairman of Wuzhou Zhongheng group, Lou shengqiong, general manager of Hangzhou rip, Jiang Hua, vice president of LVYE Pharmaceutical Group, Ke Xiao, vice president of Kanghong Pharmaceutical Group, he Yun, general manager of Liangjiang pharmaceutical R & D center, Gu Hongmei, President Assistant of Zhengda Tianqing pharmaceutical, vice president of Research Institute, Cheng Yinqi, Deputy Secretary General of China pharmaceutical innovation promotion association, Lu Xiaoti, deputy director of International Department And other members of the delegation attended the above activities.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.